NCT01635062View on ClinicalTrials.gov

The VALIDATE-D Study

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Type 2 DiabetesObesity
Interventions
DRUG

Calcitriol

Subjects will receive calcitriol (up to 0.75 mcg daily) for 3 weeks.

DRUG

Placebo

Subjects will receive placebo for 3 weeks.

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT01635062 - The VALIDATE-D Study | Biotech Hunter | Biotech Hunter